Chicago Partners Investment Group LLC Boosts Holdings in Danaher Corporation $DHR

Chicago Partners Investment Group LLC grew its position in Danaher Corporation (NYSE:DHR) by 2.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,900 shares of the conglomerate’s stock after acquiring an additional 256 shares during the period. Chicago Partners Investment Group LLC’s holdings in Danaher were worth $2,157,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in DHR. GHP Investment Advisors Inc. lifted its holdings in Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after acquiring an additional 99 shares during the period. Sierra Ocean LLC lifted its stake in shares of Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 76 shares during the period. Red Tortoise LLC boosted its holdings in Danaher by 175.0% during the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after buying an additional 98 shares in the last quarter. Smallwood Wealth Investment Management LLC purchased a new position in Danaher in the first quarter valued at about $31,000. Finally, Ramirez Asset Management Inc. purchased a new position in Danaher in the second quarter valued at about $40,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Trading Down 0.8%

Danaher stock opened at $209.14 on Monday. The stock has a market cap of $149.76 billion, a PE ratio of 44.50, a P/E/G ratio of 2.98 and a beta of 0.77. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The stock has a 50-day moving average price of $201.60 and a 200 day moving average price of $197.24. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $275.51.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to analysts’ expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm’s revenue for the quarter was up 3.4% compared to the same quarter last year. During the same period last year, the company earned $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s dividend payout ratio is currently 27.23%.

Insider Activity

In other news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 11.20% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

DHR has been the topic of a number of research reports. Barclays restated an “overweight” rating and issued a $225.00 price target (up previously from $215.00) on shares of Danaher in a report on Tuesday, June 24th. UBS Group lowered their target price on Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a report on Wednesday, July 23rd. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Danaher in a research note on Wednesday, October 8th. Royal Bank Of Canada set a $241.00 price objective on shares of Danaher in a research report on Tuesday, September 2nd. Finally, Rothschild & Co Redburn restated a “neutral” rating and set a $220.00 target price (down from $245.00) on shares of Danaher in a report on Wednesday, October 8th. Seventeen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $245.00.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.